Activation of LXRα improves cardiac remodeling induced by pulmonary artery hypertension in rats.

about

Activation of LXRα improves cardiac remodeling induced by pulmonary artery hypertension in rats.

Item

http://www.wikidata.org/entity/Q41094059

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Activation of LXRα improves ca ...... y artery hypertension in rats.

@en

type

Item

label

Activation of LXRα improves ca ...... y artery hypertension in rats.

@en

prefLabel

Activation of LXRα improves ca ...... y artery hypertension in rats.

@en

P1476

Activation of LXRα improves ca ...... y artery hypertension in rats.

@en

P2093

Can Huang

http://www.w3.org/2001/XMLSchema#string

Ge Gao

http://www.w3.org/2001/XMLSchema#string

Qin Wu

http://www.w3.org/2001/XMLSchema#string

Sijie Wu

http://www.w3.org/2001/XMLSchema#string

Yaoyao Xiong

http://www.w3.org/2001/XMLSchema#string

Yibo Gong

http://www.w3.org/2001/XMLSchema#string

Yifeng Yang

http://www.w3.org/2001/XMLSchema#string

Yin Liu

http://www.w3.org/2001/XMLSchema#string

P2860

LXR, a nuclear receptor that defines a distinct retinoid response pathway

A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha

TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling.

Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.

Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity.

Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.

Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Treatment of pulmonary arterial hypertension.

P2888

s41598-017-04640-6

P304

6169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-04640-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28733583

http://www.w3.org/2001/XMLSchema#string

P932

5522383

http://www.w3.org/2001/XMLSchema#string